NCT05499234

Brief Summary

The dural epidural tap method is performed by creating a dural perforation with a spinal needle placed through epidural needle, followed by placement of a catheter into the epidural space. No medications are administered through spinal needle. This prospective, randomized study includes 70 ASA II primigravid women with cervical dilatation between 4-6 cm and demanding epidural analgesia during spontaneous vaginal delivery.In the first group, 20 mL of 0.125% bupivacaine + 2 mcg/mL fentanyl solution and in the second group, 20 mL of 0.0625% bupivacaine + 2 mcg/mL fentanyl solution was administered as the first dose through the epidural catheter. Then, the visual analog scale (VAS) score was aimed to be below 4 in both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 2, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2023

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

August 2, 2022

Last Update Submit

February 28, 2024

Conditions

Keywords

labor analgesiadural tapconcentration

Outcome Measures

Primary Outcomes (1)

  • Change the need of bupivacaine for epidural analgesia.

    primary aim of this study is to achieve Numeric Pain Rating Scale scores equal to or below 4 via different bupivacaine concentrations. More than 4 is bad and unacceptable

    In an hour

Secondary Outcomes (1)

  • Complication comparison

    2 days

Study Arms (2)

High concentration

EXPERIMENTAL

Epidural analgesia with 20 mL of 0.125% bupivacaine + 2 mcg/mL fentanyl solution

Drug: DolantinDrug: Paracetamol

Low concentration

EXPERIMENTAL

Epidural analgesia with 20 mL of 0.0625% bupivacaine + 2 mcg/mL fentanyl solution

Drug: DolantinDrug: Paracetamol

Interventions

If VAS score is more than 4 even after additional dose, use dolantin 1 mg/kg

Also known as: Meperidin
High concentrationLow concentration

If VAS score is more than 4 even after dolantin 1 mg/kg, 10 mg/kg paracetamol IV

Also known as: Parol
High concentrationLow concentration

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ASA II primigravid women
  • with cervical dilatation between 4-6 cm, demanding epidural analgesia during spontaneous vaginal delivery

You may not qualify if:

  • Participants with pregnancy-related diseases
  • gestational hypertension
  • gestational diabetes
  • preeclampsia/ celmpsia
  • contraindications for neuraxial block
  • infection
  • coagulation disorders
  • severe hypovolemia
  • sepsis
  • neurological deficit
  • cardiac valve stenosis or hypertrophic obstructive cardiomyopathy
  • Women with fetal malpresentation and fetal anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, Bağcılar, 34700, Turkey (Türkiye)

Location

Related Publications (1)

  • Ucar FP, Danisan HG, Omur B, Alici HA, Karaaslan P. Effects of different bupivacaine concentrations with dural puncture epidural technique for labor analgesia: a prospective randomized controlled trial. BMC Anesthesiol. 2025 Nov 26;25(1):590. doi: 10.1186/s12871-025-03486-0.

MeSH Terms

Conditions

Labor Pain

Interventions

MeperidineAcetaminophen

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Isonipecotic AcidsAcids, HeterocyclicHeterocyclic CompoundsPiperidinesHeterocyclic Compounds, 1-RingAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Pınar Uçar

    Medipol University

    PRINCIPAL INVESTIGATOR
  • Emine Uzunoğlu

    Medipol University

    STUDY CHAIR
  • Pelin Karaaslan

    Medipol University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants and the medical staff administrating epidural drugs will not be told about the concentration. Because volumes will be same, they would not predict which group.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: 70 ASA II primigravid women with cervical dilatation between 4-6 cm and demanding epidural analgesia during spontaneous vaginal delivery
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 2, 2022

First Posted

August 12, 2022

Study Start

August 1, 2022

Primary Completion

October 18, 2023

Study Completion

October 18, 2023

Last Updated

March 1, 2024

Record last verified: 2024-02

Locations